Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

LD-2 disclosure · 2nd Quarter - Report

ALLSCRIPTS

via AMERICAN CAPITOL GROUP

2nd Quarter (Apr 1 - June 30) · 2008Posted Jul 10, 2008Filing document ↗LDA record ↗

Income$5Kfee reported

Client

Name: ALLSCRIPTS
Location: Illinois · United States of America

Registrant

Firm: AMERICAN CAPITOL GROUP
Description: Government Relations Firm
Location: Annandale, Virginia, United States of America

Lobbying activities

1 issue

Health Issues
COunterfeit Drug Issues, Drug Pedigrees, HR 5839, the Safeguarding America's Pharmaceuticals Act
LobbyistsJIM LINK
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

ALLSCRIPTS — Lobbying — Receipts Report